
Multidrug resistant tuberculosis – can the tide be turned?
Author(s) -
Frances M. Reid
Publication year - 2001
Language(s) - English
Resource type - Journals
ISSN - 9999-1233
DOI - 10.2807/esw.05.43.02043-en
Subject(s) - tuberculosis , rifampicin , isoniazid , multiple drug resistance , medicine , principal (computer security) , antibiotics , biology , microbiology and biotechnology , computer security , computer science , pathology
Despite the global increase in tuberculosis and the worrying rise in the number of cases resistant to the two principal antituberculosis drugs, isoniazid and rifampicin, the authors of a personal view in the current issue of the Lancet Infectious Diseases think that if action is taken now this tide can be turned (1).